Search

iRhythm Technologies Inc

Открыт

СекторЗдравоохранение

127.24 2.23

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

123.51

Макс.

127.16

Ключевые показатели

By Trading Economics

Доход

-20M

-14M

Продажи

-9.5M

199M

Прибыль на акцию

-0.35

Рентабельность продаж

-6.988

Сотрудники

2,400

EBITDA

-20M

-3.6M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+40.29% upside

Дивиденды

By Acuity

Следующий отчет о доходах

6 авг. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-453M

3.7B

Предыдущая цена открытия

125.01

Предыдущая цена закрытия

127.24

Новостные настроения

By Acuity

50%

50%

151 / 340 Рейтинг в Healthcare

iRhythm Technologies Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

3 авг. 2026 г., 20:03 UTC

iRhythm Technologies Inc shares are rising, driven by gains in the Health Care Equipment sub-sector and overall strong market performance.

31 июл. 2026 г., 21:01 UTC

iRhythm Technologies Inc shares advanced in after-hours trading, reflecting unusual strength amid rising inflation concerns and geopolitical tensions affecting oil prices.

30 июл. 2026 г., 19:43 UTC

iRhythm Technologies Inc is lower today, influenced by declines in the Health Care Equipment sub-sector. This follows five consecutive sessions of gains.

29 июл. 2026 г., 19:52 UTC

Macro Event

iRhythm Technologies shares are higher today, reflecting positive momentum after the Federal Reserve maintained interest rates amid easing inflation concerns.

28 июл. 2026 г., 18:03 UTC

iRhythm Technologies is higher today, driven by gains in the Health Care Equipment sub-sector. Shares pulled back from earlier session highs.

27 июл. 2026 г., 20:06 UTC

iRhythm Technologies Inc shares are higher amid positive market sentiment, driven by a decline in oil prices and easing geopolitical tensions.

24 июл. 2026 г., 20:06 UTC

iRhythm Technologies Inc shares are trading higher, reflecting positive sentiment amid falling oil prices that ease inflation concerns. No specific company news was identified.

23 июл. 2026 г., 09:01 UTC

iRhythm Technologies Inc is trading higher in pre-market hours, reflecting a notable gain since Wednesday's close. No specific news was identified for this movement.

21 июл. 2026 г., 18:56 UTC

News

iRhythm Technologies is under investigation for potential wrongdoing by certain officers and directors, contributing to lower trading during Tuesday's session.

20 июл. 2026 г., 19:16 UTC

iRhythm Technologies Inc is trading higher Monday, having reached a peak cumulative return earlier in the session. No specific news was identified to explain the movement.

Сравнение c конкурентами

Изменение цены

iRhythm Technologies Inc Прогноз

Целевая цена

By TipRanks

40.29% рост

Прогноз на 12 месяцев

Средняя 174.88 USD  40.29%

Максимум 255 USD

Минимум 150 USD

Основано на мнении 9 аналитиков Wall Street, спрогнозировавших целевые цены для iRhythm Technologies Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

9 ratings

9

Покупка

0

Удержание

0

Продажа

Настроения

By Acuity

151 / 340Рейтинг в Здравоохранение

Новостные настроения

Neutral

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
help-icon Live chat